CONTACT US | HOME

 

WHEEZE RATE - A New Paradigm in Asthma Management

Board of Directors

 

Mr. Peter Marks - Chairman – Australia

A venture capitalist and an investment banker, with years of experience in financing and assisting innovative technology and medical device companies. Formerly Head of Corporate Finance at Baring Securities, Head of the Melbourne Companies Department at the Australian Stock Exchange, and a Director of Corporate Finance at KPMG Australia. Currently an Executive Director of a boutique corporate advisory and investment bank.

Prof. Nathan Intrator

Prof. Nathan Intrator - Director - Israel

Widely recognized as a world expert in the field of signal processing (an area critical to the work of KSX), Prof. Intrator has over 100 peer reviewed publications in major journals and conferences.

He is also the Founder of two technology start-up companies, including one in the field of Cardio Pulmonary Interactions – an area complimentary to that of KSX. He has been responsible for the establishment, funding and expansion of these entities and brings to KSX an impressive range of technical, project management, commercial and leadership skills, including successful interactions with major funds and investors.

Prof. Intrator is also a Senior Faculty Member of the School of Computer Sciences at the University of Tel Aviv and Brown University in Providence, Rhode Island, USA.

Prof. Noam Gavriely - Founder, Director, CEO & CMO – Israel
M.D. and Ph.D. from Technion Institute in Israel

Founder and former CEO of KMAT. Prof. Gavriely is an international authority in Pulmonary Acoustics, and holds multiple patents on phonopneumography. He has extensive entrepreneurial experience, and has commercialized multiple medical devices with world-wide distribution.

Dr. Henry Pinskier

Dr. Henry Pinskier - Executive Director - Australia

Dr. Pinskier is an experienced Health Sector operator at General Practice and Hospital Sector, and Health Sector entrepreneur. He assists in interfacing with healthcare professionals who deal with asthmatic and COPD patients on a daily basis.

Mr. Amir Ohad - Executive Director & CFO - Israel

Amir holds MA degree in Economics and MBA in Finance from the Hebrew University graduated with Honors. Served as President and CEO of Kafrit Industries. Past CFO of Scitex Vision, a Digital Printers and Ink company. 

Mr. Paul Eisen - Executive Director, Sales & Marketing for Europe, Asia Pacific & Australia - Australia

Paul Eisen has operated as a senior executive in the Medical device and Healthcare industry across Australia and Asia Pacific for the last 20 years.

Paul holds a degree in Diagnostic Radiography from Sydney Technical Institute and a Graduate Diploma in Marketing from the University of Technology, Sydney ( UTS ).

 


KarmelSonix (Israel) Ltd. (KSI)
16 Palyam Avenue
Haifa 33095, Israel
Tel: +972 4 8615025 ext. 103
Fax: +972 4 8667707
Online contact
PulmoSonix Pty. Ltd.
336A Glenhuntly Road
Elsterwick, VIC 3185, Australia
Tel: +61 3 9532 4283
Fax: +61 3 9532 4141
Online contact
KarmelSonix USA.
8599 Haven Avenue, Suite 302
Rancho Cucamonga, CA 91730,  USA
Tel: +1 909 989 0033
Fax: +1 909 912 8106
Online contact

HomeContact UsAbout UsSitemapPrivacy

©2008 KarmelSonix | Design: www.121webdesign.com | Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
KarmelSonix
ISO Certification 2003
US Food & Drug Administration
US Food & Drug Administration
Australian Government
Australian Government
Therapeutic Goods Administration

CE Certification
CE Certification